Abstract
Drug use disorder, a chronic and relapsing mental disorder, is primarily diagnosed via self-reports of drug-seeking behavioral and psychological conditions, accompanied by psychiatric assessment. Therefore, the identification of peripheral biomarkers that reflect pathological changes caused by such disorders is essential for improving treatment monitoring. Hair possesses great potential as a metabolomic sample for monitoring chronic diseases. This study aimed to investigate metabolic alterations in hair to elucidate a suitable treatment modality for methamphetamine (MA) use disorder. Consequently, both targeted and untargeted metabolomics analyses were performed via mass spectrometry on hair samples obtained from current and former patients with MA use disorder. Healthy subjects (HS), current (CP), and former (FP) patients with this disorder were selected based on psychiatric diagnosis and screening the concentrations of MA in hair. The drug abuse screening questionnaire scores did not differentiate between CP and FP. Moreover, according to both targeted and untargeted metabolomics, clustering was not observed among all three groups. Nevertheless, a model of partial least squares-discriminant analysis was established between HS and CP based on seven metabolites derived from the targeted metabolomics results. Thus, this study demonstrates the promising potential of hair metabolomes for monitoring recovery from drug use disorders in clinical practice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bough KJ, Pollock JD (2018) Defining substance use disorders: the need for peripheral biomarkers. Trends Mol Med 24:109–120. https://doi.org/10.1016/j.molmed.2017.12.009
Eisenbeiss L, Binz TM, Baumgartner MR, Kraemer T, Steuer AE (2020) Towards best practice in hair metabolomic studies: systematic investigation on the impact of hair length and color. Metabolites 10:381. https://doi.org/10.3390/metabo10100381
Ghanbari R, Sumner S (2018) Using metabolomics to investigate biomarkers of drug addiction. Trends Mol Med 24:197–205. https://doi.org/10.1016/j.molmed.2017.12.005
Howells FM, Uhlmann A, Temmingh H, Sinclair H, Meintjes E, Wilson D, Stein DJ (2014) (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis. Schizophr Res 153:122–128. https://doi.org/10.1016/j.schres.2014.01.029
Hwang JS, Cha EH, Park B, Ha E, Seo JH (2020) PBN inhibits a detrimental effect of methamphetamine on brain endothelial cells by alleviating the generation of reactive oxygen species. Arch Pharm Res 43:1347–1355. https://doi.org/10.1007/s12272-020-01284-5
Jang WJ, Choi JY, Park B, Seo JH, Seo YH, Lee S, Jeong CH, Lee S (2019) Hair metabolomics in animal studies and clinical settings. Molecules 24:2195. https://doi.org/10.3390/molecules24122195
Kim JE, Kim GH, Hwang J, Kim JY, Renshaw PF, Yurgelun-Todd DA, Kim B, Kang I, Jeon S, Ma J, Lyoo IK, Yoon S (2016) Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users. Addict Biol 23:327–336. https://doi.org/10.1111/adb.12473
Kim S, Jang WJ, Yu H, Ryu IS, Jeong CH, Lee S (2019) Integrated non-targeted and targeted metabolomics uncovers dynamic metabolic effects during short-term abstinence in methamphetamine self-administering rats. J Proteome Res 18:3913–3925. https://doi.org/10.1021/acs.jproteome.9b00363
Kim S, Jang WJ, Yu H, Kim J, Lee SK, Jeong CH, Lee S (2020) Revealing metabolic perturbation following heavy methamphetamine abuse by human hair metabolomics and network analysis. Int J Mol Sci 21:6041. https://doi.org/10.3390/ijms21176041
Koob GF (2013) Addiction is a reward deficit and stress surfeit disorder. Front Psychiatry 4:72. https://doi.org/10.3389/fpsyt.2013.00072
Lee S, Han E, Park Y, Choi H, Chung H (2009) Distribution of methamphetamine and amphetamine in drug abusers’ head hair. Forensic Sci Int 190:16–18. https://doi.org/10.1016/j.forsciint.2009.05.004
Liu JF, Li JX (2018) Drug addiction: a curable mental disorder? Acta Pharmacol Sin 39:1823–1829. https://doi.org/10.1038/s41401-018-0180-x
Park SJ, Choi JW (2020) Brain energy metabolism and multiple sclerosis: progress and prospects. Arch Pharm Res 43:1017–1030. https://doi.org/10.1007/s12272-020-01278-3
Pragst F, Balikova MA (2006) State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 370:17–49. https://doi.org/10.1016/j.cca.2006.02.019
Ren W, Tao J, Wei Y, Su H, Zhang J, Xie Y, Guo J, Zhang X, Zhang H, He J (2016) Time-dependent serum brain-derived neurotrophic factor decline during methamphetamine withdrawal. Medicine 95:e2604. https://doi.org/10.1097/MD.0000000000002604
Ren W, Luan X, Zhang J, Gutteea P, Cai Y, Zhao J, Gu Y, Wu C, Su H, Tao J, Xie Y, Lv D, Feng L, He J (2017) Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal. J Affect Disord 221:165–171. https://doi.org/10.1016/j.jad.2017.06.017
Seo MJ, Song SH, Kim S, Jang WJ, Jeong CH, Lee S (2020) Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair. Arch Pharm Res 43:798–807. https://doi.org/10.1007/s12272-020-01259-6
Shin EJ, Jeong JH, Hwang Y, Sharma N, Dang DK, Nguyen BT, Nah SY, Jang CG, Bing G, Nabeshima T, Kim HC (2021) Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease. Arch Pharm Res 44:668–688. https://doi.org/10.1007/s12272-021-01341-7
Veiga S, Wahrheit J, Rodriguez-Martin A, Sonntag D (2018) Quantitative metabolomics in Alzheimer’s disease: technical considerations for improved reproducibility. Methods Mol Biol 1779:463–470. https://doi.org/10.1007/978-1-4939-7816-8_28
Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J (2001) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21:9414–9418. https://doi.org/10.1523/JNEUROSCI.21-23-09414.2001
Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS (2004) Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161:242–248. https://doi.org/10.1176/appi.ajp.161.2.242
Xie P, Wang TJ, Yin G, Yan Y, Xiao LH, Li Q, Bi KS (2016) Metabonomic study of biochemical changes in human hair of heroin abusers by liquid chromatography coupled with ion trap-time of flight mass spectrometry. J Mol Neurosci 58:93–101. https://doi.org/10.1007/s12031-015-0655-x
Xu A, Kosten TR (2020) Current status of immunotherapies for addiction. Ann N Y Acad Sci 1489:3–16. https://doi.org/10.1111/nyas.14329
Yang W, Yang R, Luo J, He L, Liu J, Zhang J (2018) Increased absolute glutamate concentrations and glutamate-to-creatine ratios in patients with methamphetamine use disorders. Front Psychiatry 9:368. https://doi.org/10.3389/fpsyt.2018.00368
Yu SB, Zhu L, Shen Q, Bai X, Di XH (2015) Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behav Neurol 2015:103969. https://doi.org/10.1155/2015/103969
Yu H, Jang WJ, Jang JH, Park B, Seo YH, Jeong CH, Lee S (2017) Role of hair pigmentation in drug incorporation into hair. Forensic Sci Int 281:171–175. https://doi.org/10.1016/j.forsciint.2017.11.004
Yu H, Choi M, Jang JH, Park B, Seo YH, Jeong CH, Bae JW, Lee S (2018) Development of a column-switching LC-MS/MS method of tramadol and its metabolites in hair and application to a pharmacogenetic study. Arch Pharm Res 41:554–563. https://doi.org/10.1007/s12272-018-1013-7
Zaitsu K, Hayashi Y, Kusano M, Tsuchihashi H, Ishii A (2016) Application of metabolomics to toxicology of drugs of abuse: a mini review of metabolomics approach to acute and chronic toxicity studies. Drug Metab Pharmacokinet 31:21–26. https://doi.org/10.1016/j.dmpk.2015.10.002
Zheng T, Liu L, Shi J, Yu X, Xiao W, Sun R, Zhou Y, Aa J, Wang G (2014) The metabolic impact of methamphetamine on the systemic metabolism of rats and potential markers of methamphetamine abuse. Mol Biosyst 10:1968–1977. https://doi.org/10.1039/c4mb00158c
Acknowledgements
This work was supported by the Basic Science Research Program (NRF-2016R1A6A1A03011325 and NRF-2018R1D1A1B07048159) through the National Research Foundation funded by the Ministry of Education in Korea.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Seo, M.J., Song, SH., Kim, S. et al. Mass spectrometry-based metabolomics in hair from current and former patients with methamphetamine use disorder. Arch. Pharm. Res. 44, 890–901 (2021). https://doi.org/10.1007/s12272-021-01353-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-021-01353-3